No. As of July 26, 2023, through analysis of the disclosure of classic Chinese medicine prescriptions in Japan, the administrative management of Japanese Kampo medicines, and analysis of patent jurisprudence, "Shanghan Lun" cannot obtain patent authorization in Japan. "Treatise on Febrile Diseases" is a classic work of traditional Chinese medicine written by Zhang Zhongjing of the Eastern Han Dynasty. It is a monograph that explains the treatment rules for exogenous diseases. It has 12 volumes. Today there are 10 volumes and 22 chapters.